+

WO1996011664A3 - Nskz 2 recepteur tyrosine-kinase musculaire - Google Patents

Nskz 2 recepteur tyrosine-kinase musculaire Download PDF

Info

Publication number
WO1996011664A3
WO1996011664A3 PCT/US1995/013490 US9513490W WO9611664A3 WO 1996011664 A3 WO1996011664 A3 WO 1996011664A3 US 9513490 W US9513490 W US 9513490W WO 9611664 A3 WO9611664 A3 WO 9611664A3
Authority
WO
WIPO (PCT)
Prior art keywords
receptor tyrosine
nsk2
tyrosine kinase
muscle receptor
muscle
Prior art date
Application number
PCT/US1995/013490
Other languages
English (en)
Other versions
WO1996011664A2 (fr
Inventor
Alastair Reith
Original Assignee
Ludwig Inst Cancer Res
Alastair Reith
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9420389A external-priority patent/GB9420389D0/en
Priority claimed from GBGB9510574.8A external-priority patent/GB9510574D0/en
Application filed by Ludwig Inst Cancer Res, Alastair Reith filed Critical Ludwig Inst Cancer Res
Priority to JP51346396A priority Critical patent/JP2002517166A/ja
Priority to EP95943567A priority patent/EP0800531A4/fr
Priority to AU45006/96A priority patent/AU4500696A/en
Publication of WO1996011664A2 publication Critical patent/WO1996011664A2/fr
Publication of WO1996011664A3 publication Critical patent/WO1996011664A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4716—Muscle proteins, e.g. myosin, actin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

L'invention concerne une nouvelle famille de récepteurs tyrosine-kinase musculaire. Les molécules d'acide nucléique codant ces derniers, ainsi que leurs utilisations.
PCT/US1995/013490 1994-10-10 1995-10-10 Nskz 2 recepteur tyrosine-kinase musculaire WO1996011664A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP51346396A JP2002517166A (ja) 1994-10-10 1995-10-10 新規な受容体チロシンキナーゼ
EP95943567A EP0800531A4 (fr) 1994-10-10 1995-10-10 Nouveaux recepteurs a activite tyrosine kinases
AU45006/96A AU4500696A (en) 1994-10-10 1995-10-10 Novel receptor tyrosine kinases

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9420389A GB9420389D0 (en) 1994-10-10 1994-10-10 Novel receptor tyrosine kinase
GB9420389.0 1994-10-10
GBGB9510574.8A GB9510574D0 (en) 1995-05-24 1995-05-24 Novel receptor tyrosine kinases
GB9510574.8 1995-05-24

Publications (2)

Publication Number Publication Date
WO1996011664A2 WO1996011664A2 (fr) 1996-04-25
WO1996011664A3 true WO1996011664A3 (fr) 1996-07-04

Family

ID=26305770

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1995/013490 WO1996011664A2 (fr) 1994-10-10 1995-10-10 Nskz 2 recepteur tyrosine-kinase musculaire

Country Status (4)

Country Link
EP (1) EP0800531A4 (fr)
JP (1) JP2002517166A (fr)
AU (1) AU4500696A (fr)
WO (1) WO1996011664A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5681714A (en) * 1992-07-30 1997-10-28 Mount Sinai Hospital Corporation Nucleic acid encoding tek receptor tyrosine kinase
AU7521196A (en) * 1995-10-27 1997-05-15 Asahi Chemical Industry Co. Ltd. Peptide inhibitors of a phosphotyrosine-binding domain containing protein
US6028053A (en) * 1995-10-27 2000-02-22 Mount Sinai Hospital Corporation Peptide inhibitors of a phosphotyrosine-binding domain containing protein

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2963395A (en) * 1994-07-20 1996-02-16 Genetics Institute Inc. Mlk receptor tyrosine kinases
JPH10505489A (ja) * 1994-07-20 1998-06-02 リジェネロン ファーマシューティカルズ， インコーポレイテッド 除神経筋キナーゼ（ｄｍｋ）、チロシンキナーゼスーパーファミリーのレセプター

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
MAMMALIAN GENOMICS, Vol. 6, No. 9, issued September 1995, REITH, "Isolation and Chromosomal Location of Nsk1, a Novel Murine Putative Receptor Tyrosine Kinase", page 689. *
ONCOGENE, Vol. 11, No. 2, issued 26 April 1995, GANJU et al., "Cloning and Developmental Expression of Nsk2, a Novel Receptor Tyrosine Kinase Implicated in Skeletal Myogenesis", pages 281-290. *
PROC. NATL. ACAD. SCI. U.S.A., Vol. 86, issued March 1989, WILKS, "Two Putative Protein-Tyrosine Kinases Identified by Application of the Polymerase Chain Reaction", pages 1603-1607. *
PROC. NATL. ACAD. SCI. U.S.A., Vol. 90, issued April 1993, JENNINGS et al., "Muscle-specific trk Related Receptor with a Kringle Domain Defines a Distinct Class of Receptor Tyrosine Kinases", pages 2895-2899. *
See also references of EP0800531A4 *

Also Published As

Publication number Publication date
EP0800531A2 (fr) 1997-10-15
AU4500696A (en) 1996-05-06
EP0800531A4 (fr) 1999-09-22
JP2002517166A (ja) 2002-06-11
WO1996011664A2 (fr) 1996-04-25

Similar Documents

Publication Publication Date Title
WO2000018914A3 (fr) NOUVEAUX POLYPEPTIDES $i(DKR)
EP0797581A4 (fr) Nouvelle tyrosine kinase proteique, jak3
TJ381B (en) Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family.
AU4651893A (en) Novel tyrosine kinase
HK1031836A1 (en) Methods of modulating serine/threonine protein kinase function with 5-azaquinoxa-line-based compounds.
EP2290079A3 (fr) Facteurs neurotrophiques
AU8143094A (en) (tie-2), a novel receptor tyrosine kinase
AU1676699A (en) Human signal transduction serine/threonine kinase
WO1999020747A3 (fr) NOUVELLE KINASE HUMAINE POINT DE CONTROLE, hCDS1, COMPOSITIONS ET METHODES ASSOCIEES
AU6244296A (en) Novel beta-xylosidase, nucleotide sequence encoding it, and use thereof
CA2336261A1 (fr) Genes et proteines cycline e2
AU7001994A (en) Mutant polypeptide of protein kinase c, nucleic acid sequences coding for said polypeptide and use thereof
AU5507098A (en) Enhancement of dna immunization through the use of cytokines
WO1996011664A3 (fr) Nskz 2 recepteur tyrosine-kinase musculaire
WO1999038981A3 (fr) Molecules de proteine kinase humaines
AU2317997A (en) Dna sequences encoding human myt1 kinase
WO2003000901A3 (fr) Acides nucleiques codant des proteines kinases
WO1998024896A3 (fr) Muteines de la proteine de l'obesite
WO1998059041A3 (fr) Nucleotides kinases apparentees aux maladies
AU7876100A (en) Isolated dishevelled associated kinases, polynucleotides encoding the kinases, and methods of use thereof
AU7130998A (en) Ethyleneimine-containing resins, manufacture, and use for chemical separations
EP1482049A3 (fr) Protéine de type Tyrosine kinase.
WO1999007854A3 (fr) Serine/threonine kinase et ses utilisations
WO1997035015A3 (fr) Proteine apparentee a la tyrosine-phosphatase
WO1999053091A3 (fr) Adn codant pour le gdnf, parties de cet adn et variantes du gdnf

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA FI JP NO NZ US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1995943567

Country of ref document: EP

122 Ep: pct application non-entry in european phase
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
WWP Wipo information: published in national office

Ref document number: 1995943567

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1995943567

Country of ref document: EP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载